Company intelligence / Profile preview

Sterling Biotech

Mumbai, Maharashtra, Indiasterlingbiotech.in ↗

Ownership: Private
Development stage: Other

Overview

Sterling Biotech was one of India's leading manufacturers of pharmaceutical-grade gelatin and fermentation-based active pharmaceutical ingredients. Its product portfolio included statins for cardiovascular therapy and anthracycline antibiotics used in oncology. The company grew to become the sixth largest producer of gelatin globally but later faced financial distress due to promoter issues. As of August 2024, it is a subsidiary under Zydus Animal Health.

Therapeutic areas: RheumatologyHematologyOncologyCardiovascular
Modalities: Small moleculeBiologic
Industry: Contract Manufacturing Organization

Partnerships

Zydus Lifesciences

Beyond the preview

Go deeper on Sterling Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sterling Biotech.

Explore the full profile